Observational studyDiabetes, obesity & metabolism2022

Significant reduction in chronic kidney disease progression with sodium-glucose cotransporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes in a UK clinical setting: An observational outcomes study based on international guidelines for kidney disease.

Iskandar Idris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.